Uniplan Investment Counsel, Inc.
Position in AUPH — Aurinia Pharmaceuticals Inc.
CIK 1520710
MILWAUKEE, WI
Position in AUPH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,216,527
+$1,518,141 QoQ
Shares Held
189,542
+65.4% QoQ
Ownership
0.142%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#61
of 279 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AUPH Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Uniplan Investment Counsel, Inc. holds $24,931,715 across 4 Biotechnology names. AUPH ranks #4 (12.9% of the industry book) .
All Filings in AUPH
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,216,527 | 189,542 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,698,386 | 114,601 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,003,574 | 125,616 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $1,011,704 | 91,557 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||